Concepedia

Peter C. Gareiss

PC

Statistics

Publications

21

Citations

2.8K

H-Index

17

Active since

2006

Affiliations

Yale University(Current)

University of Rochester

National Cancer Institute

Frederick National Laboratory for Cancer Research

University of Cambridge

Peter C. Gareiss is an author at Yale University specializing in drug discovery, molecular biology, and ligand binding.

Publications per year

2006–2024

21

Publications

21

An analysis of FDA-approved drugs: natural products and their derivatives

Eric Patridge, Peter C. Gareiss, Michael S. Kinch · Drug Discovery Today · 2015 · 819 citations

Pharmacy, Medicinal Chemistry, Pharmacology +14

Targeting the von Hippel–Lindau E3 Ubiquitin Ligase Using Small Molecules To Disrupt the VHL/HIF-1α Interaction

Dennis L. Buckley, Inge Van Molle, Peter C. Gareiss et al. · Journal of the American Chemical Society · 2012 · 558 citations · Full text

Pharmacy, Medicinal Chemistry, Molecular Biology +17

Small‐Molecule Inhibitors of the Interaction between the E3 Ligase VHL and HIF1α

Dennis L. Buckley, Jeffrey L. Gustafson, Inge Van Molle et al. · Angewandte Chemie International Edition · 2012 · 286 citations

Pharmacy, Medicinal Chemistry, Molecular Biology +14

Dynamic Combinatorial Selection of Molecules Capable of Inhibiting the (CUG) Repeat RNA−MBNL1 Interaction In Vitro: Discovery of Lead Compounds Targeting Myotonic Dystrophy (DM1)

Peter C. Gareiss, Krzysztof Sobczak, Brian R. McNaughton et al. · Journal of the American Chemical Society · 2008 · 187 citations

Life Sciences, Medicinal Chemistry, Molecular Biology +14

Identification of Biologically Active, HIV TAR RNA-Binding Small Molecules Using Small Molecule Microarrays

Joanna Sztuba-Solińska, Shilpa R. Shenoy, Peter C. Gareiss et al. · Journal of the American Chemical Society · 2014 · 142 citations · Full text

Pharmacy, Medicinal Chemistry, Drug Design +12

1–5 of 21